These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8886287)

  • 1. Susceptibility of growth factors to degradation by Helicobacter pylori protease: effect of ebrotidine and sucralfate.
    Slomiany BL; Piotrowski J; Slomiany A
    Biochem Mol Biol Int; 1996 Sep; 40(1):209-15. PubMed ID: 8886287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ebrotidine effect on the proteolytic and lipolytic activities of Helicobacter pylori.
    Slomiany BL; Piotrowski J; Mojtahed H; Slomiany A
    Gen Pharmacol; 1992 Mar; 23(2):203-6. PubMed ID: 1639232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sucralfate on the degradation of human gastric mucus by Helicobacter pylori protease and lipases.
    Slomiany BL; Piotrowski J; Slomiany A
    Am J Gastroenterol; 1992 May; 87(5):595-9. PubMed ID: 1595646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of Helicobacter pylori protease activity towards growth factors by sulglycotide.
    Piotrowski J; Slomiany A; Slomiany BL
    J Physiol Pharmacol; 1997 Sep; 48(3):345-51. PubMed ID: 9376617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of Helicobacter pylori to antimicrobial agents: effect of ebrotidine and ranitidine.
    Piotrowski J; Piotrowski E; Slomiany A; Slomiany BL
    J Physiol Pharmacol; 1995 Dec; 46(4):463-9. PubMed ID: 8770790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Helicobacter pylori activities of ebrotidine. A review of biochemical and animal experimental studies and data.
    Slomiany BL; Piotrowski J; Slomiany A
    Arzneimittelforschung; 1997 Apr; 47(4A):475-82. PubMed ID: 9205747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ebrotidine on gastric mucosal EGF and PDGF receptor expression.
    Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A; Slomiany BL
    Biochem Mol Biol Int; 1993 Aug; 30(6):1127-34. PubMed ID: 8106073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Helicobacter pylori urease activity by ebrotidine.
    Piotrowski J; Slomiany A; Slomiany BL
    Biochem Mol Biol Int; 1995 Oct; 37(2):247-53. PubMed ID: 8673007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro anti-Helicobacter pylori activity of ebrotidine.
    Palacín C; Tarragó C; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):471-4. PubMed ID: 9205746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of Helicobacter pylori urease activity by sucralfate and sulglycotide.
    Slomiany BL; Piotrowski J; Slomiany A
    Biochem Mol Biol Int; 1997 Jun; 42(1):155-61. PubMed ID: 9192095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori aggregating activity of gastric mucin with ulcer healing by ebrotidine.
    Piotrowski J; Majka J; Piotrowski E; Murty VL; Gabryelewicz A; Slomiany A; Slomiany BL
    Biochem Mol Biol Int; 1994 Nov; 34(5):875-81. PubMed ID: 7535617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ebrotidine.
    Patel SS; Wilde MI
    Drugs; 1996 Jun; 51(6):974-80; discussion 981. PubMed ID: 8736619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of gastric mucosal mucin receptor by H. pylori lipopolysaccharide: effect of ebrotidine.
    Slomiany BL; Piotrowski J; Murty VL; Slomiany A
    Gen Pharmacol; 1995 Nov; 26(7):1553-8. PubMed ID: 8690245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ebrotidine on gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide.
    Slomiany BL; Piotrowski J; Slomiany A
    J Physiol Pharmacol; 1999 Sep; 50(3):391-404. PubMed ID: 10574469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric mucosal EGF and PDGF receptor expression with ulcer healing by ebrotidine.
    Slomiany BL; Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A
    Am J Gastroenterol; 1994 Jun; 89(6):894-7. PubMed ID: 8198101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ebrotidine--a nostrum for ulcer.
    Grover JK; Rathi SS; Vats V
    Trop Gastroenterol; 1997; 18(3):111-3. PubMed ID: 9385853
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversal of gastric somatostatin receptor inhibition by Helicobacter pylori lipopolysaccharide with ebrotidine and sulglycotide.
    Piotrowski J; Skrodzka D; Slomiany A; Slomiany BL
    Gen Pharmacol; 1997 May; 28(5):705-8. PubMed ID: 9184806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ebrotidine].
    Elizalde JI
    Gastroenterol Hepatol; 1997 Feb; 20(2):65-7. PubMed ID: 9072206
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the cytoprotective and antisecretory activity of ebrotidine. A review.
    Konturek PC; Brzozowski T; Konturek SI; Márquez M; Torres J; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):578-89. PubMed ID: 9205769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroprotective properties of ebrotidine. A review.
    Slomiany BL; Piotrowski J; Slomiany A
    Arzneimittelforschung; 1997 Apr; 47(4A):459-67. PubMed ID: 9205744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.